Teva Pharmaceutical Industries Limited - 예탁증서(보통주)
AT ˙ WBAG ˙ US8816242098
€30.30 ↑0.90 (3.06%)
2026-06-05
주가
SecurityAT:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionBlackRock, Inc.
Latest Disclosed Ownership65,136,464 shares
Latest Disclosed Value $ 1,961,910,299
BlackRock, Inc. ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 65,136,464 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (AT:TEVA) valued at $1,647,952,539 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 58,302,688 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of 11.72% during the quarter. The current value of the position is $1,973,634,859 USD.

BlackRock, Inc. has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AT:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 65,136,464 6,833,776 11.72 1,961,910 7.82 0.0343
2026-02-12 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 58,302,688 500,280 0.87 1,819,627 55.84 0.0308
2025-11-12 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 57,802,408 3,484,026 6.41 1,167,609 28.26 0.0204
2025-08-12 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 54,318,382 2,094,489 4.01 910,376 13.42 0.0173
2025-05-02 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 52,223,893 1,640,067 3.24 802,681 -28.00 0.0169
2025-02-07 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 50,583,826 6,783,663 15.49 1,114,868 41.25 0.0226
2024-11-13 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 43,800,163 812,381 1.89 789,279 12.99 0.0166
2024-08-13 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 42,987,782 -716,619 -1.64 698,551 13.28 0.0158
2024-05-10 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 43,704,401 2,039,540 4.90 616,669 41.77 0.0144
2024-02-13 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 41,664,861 881,566 2.16 434,981 4.57 0.0111
2023-11-13 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 40,783,295 493,488 1.22 415,990 37.12 0.0120
2023-08-11 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 40,289,807 123,426 0.31 303,382 -14.65 0.0084
2023-05-12 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 40,166,381 -190,344 -0.47 355,472 -3.42 0.0105
2023-02-13 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 40,356,725 -1,310,529 -3.15 368,053 9.46 0.0115
2022-11-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 41,667,254 -1,410,349 -3.27 336,256 3.80 0.0114
2022-08-12 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 43,077,603 1,428,887 3.43 323,943 -17.17 0.0104
2022-05-12 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 41,648,716 1,494,814 3.72 391,081 21.59 0.0105
2022-02-10 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 40,153,902 -387,943 -0.96 321,634 -18.55 0.0082
2021-11-09 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 40,541,845 785,802 1.98 394,877 0.33 0.0111
2021-08-11 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 39,756,043 -2,228,410 -5.31 393,587 -18.76 0.0110
2021-05-07 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 41,984,453 4,748,989 12.75 484,500 34.84 0.0142
2021-02-05 2020-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 37,235,464 -772,165 -2.03 359,322 4.93 0.0115
2020-11-06 2020-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 38,007,629 388,509 1.03 342,446 -26.17 0.0126
2020-08-14 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 37,619,120 -117,187 -0.31 463,844 36.88 0.0185
2020-05-01 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 37,736,307 1,671,984 4.64 338,871 -4.12 0.0166
2020-02-13 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 36,064,323 526,979 1.48 353,432 44.56 0.0136
2019-11-08 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 35,537,344 578,947 1.66 244,496 -24.23 0.0103
2019-08-22 2019-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 34,958,397 1,175,800 3.48 322,668 -39.09 0.0138
2019-08-13 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 34,958,397 1,175,800 322,668
2019-05-09 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 33,782,597 42,498 0.13 529,710 1.81 0.0236
2019-02-08 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 33,740,099 658,864 1.99 520,273 -26.99 0.0263
2018-11-09 2018-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 33,081,235 1,122,592 3.51 712,571 -8.32 0.0308
2018-08-09 2018-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 31,958,643 3,043,358 10.53 777,236 57.28 0.0358
2018-05-09 2018-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 28,915,285 -905,961 -3.04 494,161 -12.56 0.0236
2018-02-09 2017-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 29,821,246 611,815 2.09 565,112 9.93 0.0269
2017-11-14 2017-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 29,209,431 1,719,511 6.26 514,085 -43.71 0.0259
2017-08-10 2017-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 27,489,920 -299,228 -1.08 913,216 2.41 0.0484
2017-05-12 2017-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 27,789,148 26,296,961 1,762.31 891,752 1,548.58 0.0490
2017-02-10 2016-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 1,492,187 988,954 196.52 54,092 133.63 0.0766
2016-11-08 2016-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 503,233 -67,972 -11.90 23,153 -19.30 0.0332
2016-08-10 2016-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 571,205 -77,799 -11.99 28,691 -17.38 0.0432
2016-05-10 2016-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 649,004 14,609 2.30 34,728 -16.60 0.0559
2016-02-11 2015-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 634,395 -114,685 -15.31 41,642 -1.54 0.0611
2015-11-13 2015-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 749,080 -107,153 -12.51 42,293 -16.42 0.0663
2015-08-07 2015-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 856,233 49,312 6.11 50,604 0.66 0.0750
2015-05-13 2015-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 806,921 244,983 43.60 50,271 55.56 0.0695
2015-02-09 2014-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 561,938 51,242 10.03 32,317 17.73 0.0462
2014-10-29 2014-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 510,696 330,955 184.13 27,450 191.34 0.0401
2014-08-06 2014-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 179,741 1,813 1.02 9,422 0.22 0.0140
2014-05-02 2014-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 177,928 177,928 9,401 0.0152
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-05-09 2019-03-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-08 2018-12-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Call 5,000 -97.14 77 -99.17 n/a n/a n/a
2014-05-02 2014-03-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Call 175,000 9,247 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-02-05 2020-12-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-06 2020-09-30 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 180,000 -28.00 1,622 -47.37 n/a n/a n/a
2020-08-14 2020-06-30 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 250,000 -67.32 3,082 -55.14 n/a n/a n/a
2020-05-01 2020-03-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 765,000 12.25 6,871 2.87 n/a n/a n/a
2020-02-13 2019-12-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 681,500 43.02 6,679 103.75 n/a n/a n/a
2019-11-08 2019-09-30 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 476,500 79.14 3,278 33.52 n/a n/a n/a
2019-08-22 2019-06-30 13F/A TEVA PHARMACEUTICAL INDS OPTIONS Put 266,000 416.50 2,455 203.84 n/a n/a n/a
2019-08-13 2019-06-30 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 266,000 2,455 n/a n/a n/a
2019-05-09 2019-03-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 51,500 0.00 808 1.76 n/a n/a n/a
2019-02-08 2018-12-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 51,500 -84.70 794 -89.05 n/a n/a n/a
2018-11-09 2018-09-30 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 336,500 7,249 n/a n/a n/a
2018-08-09 2018-06-30 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-09 2018-03-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 86,000 -68.09 1,470 -71.22 n/a n/a n/a
2018-02-09 2017-12-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 269,500 5,107 n/a n/a n/a
2016-08-10 2016-06-30 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-10 2016-03-31 13F TEVA PHARMACEUTICAL INDS OPTIONS Put 12,000 642 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.